Boston Scientific Corp. has exercised its option to acquire the remaining shares of University of Iowa startup Farapulse Inc., which has developed a method for precisely and safely treating abnormal heart rhythms.

Luis Miguel Garcia Pena says that even though he had experience working in a genetics laboratory as an undergraduate and doing epidemiological and clinical research for Harvard’s school of public health, his “bench skill set was limited.” Before applying to graduate schools, he began looking for research opportunities on the National Institutes of Health (NIH) website, where he saw a listing for a small program in Iowa, that could bolster that skill set.

Years of research have led to a greater understanding of how cancers hide from the immune system—and a promising immunotherapy treatment for melanoma.

UI Heart and Vascular Center offers highly specialized, less-invasive heart therapies

Dr. Philip Polgreen and his collaborators received a five-year, $3.7M R01 grant from the National Institute of Allergy and Infectious Diseasesto support the upcoming project titled, “Estimating the risk for and severity of respiratory infections attributable to CFTR heterozygosity.”

Isabella Grumbach, MD, PhD, professor in Cardiovascular Medicine and Vice Chair for Research, was nominated and elected to the Association of University Cardiologists (AUC), a national organization for the country’s leaders in academic cardiology.

Led by Phillip Horwitz, MD, and James Rossen, MD, the UI Health Care Heart and Vascular team is the first in the state to perform a procedure called intravascular lithotripsy that uses sonic pressure waves to break up calcium build-up in heart arteries.